251 related articles for article (PubMed ID: 21923443)
21. The effect of rofecoxib on the pharmacodynamics and pharmcokinetics of warfarin.
Schwartz JI; Bugianesi KJ; Ebel DL; De Smet M; Haesen R; Larson PJ; Ko A; Verbesselt R; Hunt TL; Lins R; Lens S; Porras AG; Dieck J; Keymeulen B; Gertz BJ
Clin Pharmacol Ther; 2000 Dec; 68(6):626-36. PubMed ID: 11180023
[TBL] [Abstract][Full Text] [Related]
22. Moxifloxacin-acetaminophen-warfarin interaction during bacille Calmette-Guerin treatment for bladder cancer.
Lee R; Wen A; Berube C
Am J Health Syst Pharm; 2011 May; 68(9):814-7. PubMed ID: 21515865
[TBL] [Abstract][Full Text] [Related]
23. An algorithm for managing warfarin resistance.
Osinbowale O; Al Malki M; Schade A; Bartholomew JR
Cleve Clin J Med; 2009 Dec; 76(12):724-30. PubMed ID: 19952297
[TBL] [Abstract][Full Text] [Related]
24. Critically elevated INR in a patient on warfarin after increase in extended-release niacin dose.
Christopher A
Ann Pharmacother; 2011 Nov; 45(11):e58. PubMed ID: 22010004
[TBL] [Abstract][Full Text] [Related]
25. Does heart failure exacerbation increase response to warfarin? A critical review of the literature.
Self TH; Reaves AB; Oliphant CS; Sands C
Curr Med Res Opin; 2006 Nov; 22(11):2089-94. PubMed ID: 17076968
[TBL] [Abstract][Full Text] [Related]
26. Paracetamol: a haemorrhagic risk factor in patients on warfarin.
Mahé I; Bertrand N; Drouet L; Simoneau G; Mazoyer E; Bal dit Sollier C; Caulin C; Bergmann JF
Br J Clin Pharmacol; 2005 Mar; 59(3):371-4. PubMed ID: 15752384
[TBL] [Abstract][Full Text] [Related]
27. Delayed elevation of international normalized ratio with concurrent clarithromycin and warfarin therapy.
Oberg KC
Pharmacotherapy; 1998; 18(2):386-91. PubMed ID: 9545160
[TBL] [Abstract][Full Text] [Related]
28. Interactions between warfarin and three commonly prescribed fluoroquinolones.
Carroll DN; Carroll DG
Ann Pharmacother; 2008 May; 42(5):680-5. PubMed ID: 18413687
[TBL] [Abstract][Full Text] [Related]
29. Warfarin and acetaminophen interaction: a summary of the evidence and biologic plausibility.
Lopes RD; Horowitz JD; Garcia DA; Crowther MA; Hylek EM
Blood; 2011 Dec; 118(24):6269-73. PubMed ID: 21911832
[TBL] [Abstract][Full Text] [Related]
30. Low-molecular-weight heparin may alter point-of-care assay for international normalized ratio.
Phillips EM; Buchan DA; Newman N; Rajan A; Zia S
Pharmacotherapy; 2005 Oct; 25(10):1341-7. PubMed ID: 16185178
[TBL] [Abstract][Full Text] [Related]
31. Single-dose adjustment versus no adjustment of warfarin in stably anticoagulated patients with an occasional international normalized ratio (INR) out of range.
Schulman S; Melinyshyn A; Ennis D; Rudd-Scott L
Thromb Res; 2010 May; 125(5):393-7. PubMed ID: 19640572
[TBL] [Abstract][Full Text] [Related]
32. Warfarin-acetaminophen interaction.
Med Lett Drugs Ther; 2008 Jun; 50(1288):45. PubMed ID: 18551088
[No Abstract] [Full Text] [Related]
33. Relationship between chromogenic factor X and international normalized ratio differs during early warfarin initiation compared with chronic warfarin administration.
Rosborough TK; Jacobsen JM; Shepherd MF
Blood Coagul Fibrinolysis; 2009 Sep; 20(6):433-5. PubMed ID: 19543077
[TBL] [Abstract][Full Text] [Related]
34. Interaction between warfarin and cranberry juice.
Paeng CH; Sprague M; Jackevicius CA
Clin Ther; 2007 Aug; 29(8):1730-5. PubMed ID: 17919554
[TBL] [Abstract][Full Text] [Related]
35. Phytonadione therapy in a multiple-drug overdose involving warfarin.
Bates D; Mintz M
Pharmacotherapy; 2000 Oct; 20(10):1208-15. PubMed ID: 11034045
[TBL] [Abstract][Full Text] [Related]
36. An evaluation of the early pharmacodynamic response after simultaneous initiation of warfarin and amiodarone.
Edwin SB; Jennings DL; Kalus JS
J Clin Pharmacol; 2010 Jun; 50(6):693-8. PubMed ID: 20081064
[TBL] [Abstract][Full Text] [Related]
37. Effect of carbamazepine initiation and discontinuation on antithrombotic control in a patient receiving warfarin: case report and review of the literature.
Parrish RH; Pazdur DE; O'donnell PJ
Pharmacotherapy; 2006 Nov; 26(11):1650-3. PubMed ID: 17064211
[TBL] [Abstract][Full Text] [Related]
38. Decreased INR response secondary to warfarin-flucloxacillin interaction.
Garg A; Mohammed M
Ann Pharmacother; 2009 Jul; 43(7):1374-5. PubMed ID: 19584391
[No Abstract] [Full Text] [Related]
39. Increasing warfarin dosage reductions associated with concurrent warfarin and repeated cycles of 5-Fluorouracil therapy.
Davis DA; Fugate SE
Pharmacotherapy; 2005 Mar; 25(3):442-7. PubMed ID: 15843293
[TBL] [Abstract][Full Text] [Related]
40. Increased warfarin doses and decreased international normalized ratio response after nationwide generic switching.
Halkin H; Shapiro J; Kurnik D; Loebstein R; Shalev V; Kokia E
Clin Pharmacol Ther; 2003 Sep; 74(3):215-21. PubMed ID: 12966365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
